• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环氧化酶与心血管系统。

Cyclooxygenases and the cardiovascular system.

作者信息

Mitchell Jane A, Kirkby Nicholas S, Ahmetaj-Shala Blerina, Armstrong Paul C, Crescente Marilena, Ferreira Plinio, Lopes Pires Maria Elisa, Vaja Ricky, Warner Timothy D

机构信息

Cardiothoracic Pharmacology, National Heart and Lung Institute, Imperial College London, SW7 2AZ, United Kingdom.

Cardiothoracic Pharmacology, National Heart and Lung Institute, Imperial College London, SW7 2AZ, United Kingdom.

出版信息

Pharmacol Ther. 2021 Jan;217:107624. doi: 10.1016/j.pharmthera.2020.107624. Epub 2020 Jul 5.

DOI:10.1016/j.pharmthera.2020.107624
PMID:32640277
Abstract

Cyclooxygenase (COX)-1 and COX-2 are centrally important enzymes within the cardiovascular system with a range of diverse, sometimes opposing, functions. Through the production of thromboxane, COX in platelets is a pro-thrombotic enzyme. By contrast, through the production of prostacyclin, COX in endothelial cells is antithrombotic and in the kidney regulates renal function and blood pressure. Drug inhibition of COX within the cardiovascular system is important for both therapeutic intervention with low dose aspirin and for the manifestation of side effects caused by nonsteroidal anti-inflammatory drugs. This review focuses on the role that COX enzymes and drugs that act on COX pathways have within the cardiovascular system and provides an in-depth resource covering COX biology and pharmacology. The review goes on to consider the role of COX in both discrete cardiovascular locations and in associated organs that contribute to cardiovascular health. We discuss the importance of, and strategies to manipulate the thromboxane: prostacyclin balance. Finally within this review the authors discuss testable COX-2-hypotheses intended to stimulate debate and facilitate future research and therapeutic opportunities within the field.

摘要

环氧化酶(COX)-1和COX-2是心血管系统中至关重要的酶,具有一系列多样的、有时甚至相互对立的功能。血小板中的COX通过生成血栓素,是一种促血栓形成酶。相比之下,内皮细胞中的COX通过生成前列环素,具有抗血栓形成作用,并在肾脏中调节肾功能和血压。心血管系统中对COX的药物抑制对于低剂量阿司匹林的治疗干预以及非甾体抗炎药引起的副作用表现都很重要。本综述重点关注COX酶和作用于COX途径的药物在心血管系统中的作用,并提供了涵盖COX生物学和药理学的深入资源。该综述接着探讨了COX在离散的心血管部位以及对心血管健康有贡献的相关器官中的作用。我们讨论了调节血栓素:前列环素平衡的重要性及策略。最后,在本综述中,作者讨论了可检验的COX-2假说,旨在激发辩论并促进该领域未来的研究和治疗机会。

相似文献

1
Cyclooxygenases and the cardiovascular system.环氧化酶与心血管系统。
Pharmacol Ther. 2021 Jan;217:107624. doi: 10.1016/j.pharmthera.2020.107624. Epub 2020 Jul 5.
2
Nitric oxide, anti-inflammatory drugs on renal prostaglandins and cyclooxygenase-2.一氧化氮、抗炎药物对肾前列腺素和环氧化酶-2的影响
Hypertension. 2002 Mar 1;39(3):785-9. doi: 10.1161/hy0302.105689.
3
Cardiovascular pharmacology of nonselective nonsteroidal anti-inflammatory drugs and coxibs: clinical considerations.非选择性非甾体抗炎药与环氧化酶-2选择性抑制剂的心血管药理学:临床考量
Am J Cardiol. 2002 Mar 21;89(6A):26D-32D. doi: 10.1016/s0002-9149(02)02234-8.
4
Vane's discovery of the mechanism of action of aspirin changed our understanding of its clinical pharmacology.Vane 发现了阿司匹林的作用机制,改变了我们对其临床药理学的理解。
Pharmacol Rep. 2010 May-Jun;62(3):518-25. doi: 10.1016/s1734-1140(10)70308-x.
5
Cyclooxygenase inhibitors: instrumental drugs to understand cardiovascular homeostasis and arterial thrombosis.环氧化酶抑制剂:理解心血管稳态和动脉血栓形成的重要药物。
Cardiovasc Hematol Disord Drug Targets. 2008 Dec;8(4):268-77. doi: 10.2174/187152908786786250.
6
Dual acting anti-inflammatory drugs: a reappraisal.双效抗炎药物:重新评估
Pharmacol Res. 2001 Dec;44(6):437-50. doi: 10.1006/phrs.2001.0872.
7
Selective COX-2 inhibition and cardiovascular effects: a review of the rofecoxib development program.选择性环氧化酶-2抑制作用与心血管效应:罗非昔布研发项目综述
Am Heart J. 2003 Oct;146(4):591-604. doi: 10.1016/S0002-8703(03)00398-3.
8
The metabolic effects of inhibitors of 5-lipoxygenase and of cyclooxygenase 1 and 2 are an advancement in the efficacy and safety of anti-inflammatory therapy.5-脂氧合酶以及环氧化酶1和2抑制剂的代谢效应是抗炎治疗在疗效和安全性方面的一项进展。
Prostaglandins Other Lipid Mediat. 2003 Jul;71(3-4):147-62. doi: 10.1016/s1098-8823(03)00039-x.
9
Cyclooxygenase-2 inhibitors in tumorigenesis (Part II).环氧化酶-2抑制剂在肿瘤发生中的作用(第二部分)
J Natl Cancer Inst. 1998 Nov 4;90(21):1609-20. doi: 10.1093/jnci/90.21.1609.
10
Inhibitors of cyclooxygenases: mechanisms, selectivity and uses.环氧化酶抑制剂:作用机制、选择性及应用
J Physiol Pharmacol. 2006 Nov;57 Suppl 5:113-24.

引用本文的文献

1
Arachidonic acid metabolism in metabolic dysfunction-associated steatotic liver disease and liver fibrosis.代谢功能障碍相关脂肪性肝病和肝纤维化中的花生四烯酸代谢
Hepatol Commun. 2025 Aug 29;9(9). doi: 10.1097/HC9.0000000000000802. eCollection 2025 Sep 1.
2
Exploring the effects of capsule in microcirculatory dysfunction model rats through laser speckle contrast imaging and metabolomics.通过激光散斑对比成像和代谢组学探索胶囊对微循环功能障碍模型大鼠的影响。
Front Pharmacol. 2025 Aug 11;16:1647514. doi: 10.3389/fphar.2025.1647514. eCollection 2025.
3
Targeting the E Prostanoid Receptor EP4 Mitigates Cardiac Fibrosis Induced by β-Adrenergic Activation.
靶向E前列腺素受体EP4可减轻β-肾上腺素能激活诱导的心脏纤维化。
Adv Sci (Weinh). 2025 Mar;12(12):e2413324. doi: 10.1002/advs.202413324. Epub 2025 Feb 7.
4
Cardiovascular Implications of Non-steroidal Anti-inflammatory Drugs: A Comprehensive Review, with Emphasis on Patients with Rheumatoid Arthritis.非甾体抗炎药对心血管系统的影响:全面综述,重点关注类风湿关节炎患者
Eur Cardiol. 2024 Dec 23;19:e27. doi: 10.15420/ecr.2024.24. eCollection 2024.
5
Role of aspirin in the primary prevention of cardiovascular disease in patients with hyperlipoproteinaemia(a).阿司匹林在高脂蛋白血症(a)患者心血管疾病一级预防中的作用。
Drugs Context. 2024 Dec 31;13. doi: 10.7573/dic.2024-10-2. eCollection 2024.
6
Eremophilane- and Acorane-Type Sesquiterpenes from the Deep-Sea Cold-Seep-Derived Fungus CS-280 Cultured in the Presence of Autoclaved QDIO-4.在经高压灭菌的QDIO-4存在下培养的深海冷泉来源真菌CS-280中的桉烷型和菖蒲烷型倍半萜
Mar Drugs. 2024 Dec 22;22(12):574. doi: 10.3390/md22120574.
7
Vascular and inflammatory biomarkers of cardiovascular events in non-steroidal anti-inflammatory drug users.非甾体抗炎药使用者心血管事件的血管和炎症生物标志物
Eur Heart J Open. 2024 Nov 2;4(6):oeae088. doi: 10.1093/ehjopen/oeae088. eCollection 2024 Nov.
8
Recent advances in surface functionalization of cardiovascular stents.心血管支架表面功能化的最新进展。
Bioact Mater. 2024 Oct 28;44:389-410. doi: 10.1016/j.bioactmat.2024.10.025. eCollection 2025 Feb.
9
Senescence and Inflamm-Aging Are Associated With Endothelial Dysfunction in Men But Not Women With Atherosclerosis.衰老和炎症衰老与男性而非患有动脉粥样硬化的女性的内皮功能障碍有关。
JACC Basic Transl Sci. 2024 Sep 4;9(10):1163-1177. doi: 10.1016/j.jacbts.2024.06.012. eCollection 2024 Oct.
10
Identification of metabolites from the gut microbiota in hypertension via network pharmacology and molecular docking.通过网络药理学和分子对接鉴定高血压患者肠道微生物群中的代谢产物
Bioresour Bioprocess. 2024 Oct 21;11(1):102. doi: 10.1186/s40643-024-00815-y.